Gesval S.A.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 8, 2027The maintenance fee for Ketamine flow synthesis (US 11,718,578) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
- 1 fee due Jul 9, 2027The maintenance fee for Methods Involving Nucleic Acid Analysis of Milk (US 11,866,776) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,931,396 | Koi herpesvirus vaccine In force · USPTO record | In force | USPTO record | |
| US 10,905,691 | New Use of TRIAZOLO(4,5 D)pyrimidine Derivatives for Prevention and Treatment of Bacterial Infection In force · Medium confidence | In force | Medium confidence | |
| US 11,286,230 | Ketamine flow synthesis In force · USPTO record | In force | USPTO record | |
| US 11,718,578 | Ketamine flow synthesis In force · USPTO record | In force | USPTO record | |
| US 11,866,776 | Methods Involving Nucleic Acid Analysis of Milk In force · High confidence | In force | High confidence | |
| US 11,541,129 | Nanoreservoir coated medical devices, biomaterials, and bioprosthetics In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 6: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending
Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/694,237 | Cassette Configured to Contain a Microfluidic Chip | Sep 21, 2022 | Pending |
| 18/694,002 | Accessory for a Plate of a Microfluidic Experimentation Device, and Microfluidic Experimentation Device | Sep 21, 2022 | Pending |
| 18/291,332 | Cell-Free Trna Fragment-Based Tr-Fret Screening and Competition Assay for Inhibitors of Human Trna Modification Enzymes Useful in the Prevention or Treatment of Trna Modification Related Conditions | Jul 16, 2022 | Pending |
| 18/284,924 | Tnra Modification-Sensitive Codon Translation Assay Comprising Luminescence-Based Reporter System | Feb 27, 2022 | Pending |
| 18/016,194 | Container System for Receiving a Liquid Sample | Jul 13, 2021 | Pending |